搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Conus litteratus Conotoxin Lt9a CSB-YP645334DWB
CSB-EP645334DWB
CSB-BP645334DWB
CSB-MP645334DWB
CSB-EP645334DWB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Conus litteratus Conotoxin Lt7.1 CSB-YP645335DWB
CSB-EP645335DWB
CSB-BP645335DWB
CSB-MP645335DWB
CSB-EP645335DWB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Conus litteratus Alpha-conotoxin-like Lt1.3 CSB-YP645336DWB
CSB-EP645336DWB
CSB-BP645336DWB
CSB-MP645336DWB
CSB-EP645336DWB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Elephas maximus NADH-ubiquinone oxidoreductase chain 5 (MT-ND5), partial CSB-YP645337EKA
CSB-EP645337EKA
CSB-BP645337EKA
CSB-MP645337EKA
CSB-EP645337EKA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Elephas maximus Cytochrome c oxidase subunit 2 (MT-CO2), partial CSB-YP645338EKA1
CSB-EP645338EKA1
CSB-BP645338EKA1
CSB-MP645338EKA1
CSB-EP645338EKA1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Callithrix jacchus Catalase (CAT), partial CSB-YP645339CYL
CSB-EP645339CYL
CSB-BP645339CYL
CSB-MP645339CYL
CSB-EP645339CYL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlorocebus aethiops Hepatocyte growth factor receptor (MET), partial CSB-YP645340DSU
CSB-EP645340DSU
CSB-BP645340DSU
CSB-MP645340DSU
CSB-EP645340DSU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhinolophus ferrumequinum Cystic fibrosis transmembrane conductance regulator (CFTR), partial CSB-YP645341RKD
CSB-EP645341RKD
CSB-BP645341RKD
CSB-MP645341RKD
CSB-EP645341RKD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rat Caveolin-2 (Cav2) CSB-YP645342RA
CSB-EP645342RA
CSB-BP645342RA
CSB-MP645342RA
CSB-EP645342RA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gorilla gorilla gorilla F-actin-capping protein subunit alpha-2 (CAPZA2) CSB-YP645343GGZ
CSB-EP645343GGZ
CSB-BP645343GGZ
CSB-MP645343GGZ
CSB-EP645343GGZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gorilla gorilla gorilla Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 (ASZ1) CSB-YP645344GGZ
CSB-EP645344GGZ
CSB-BP645344GGZ
CSB-MP645344GGZ
CSB-EP645344GGZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Influenza A virus Polymerase basic protein 2 (PB2), partial CSB-YP645345IFJ
CSB-EP645345IFJ
CSB-BP645345IFJ
CSB-MP645345IFJ
CSB-EP645345IFJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Influenza A virus Nuclear export protein (NS) CSB-YP645346IFJ
CSB-EP645346IFJ
CSB-BP645346IFJ
CSB-MP645346IFJ
CSB-EP645346IFJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anaeromyxobacter dehalogenans Non-canonical purine NTP pyrophosphatase (Adeh_3360) CSB-YP645347AAAP
CSB-EP645347AAAP
CSB-BP645347AAAP
CSB-MP645347AAAP
CSB-EP645347AAAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anaeromyxobacter dehalogenans CinA-like protein (Adeh_3614) CSB-YP645348AAAP
CSB-EP645348AAAP
CSB-BP645348AAAP
CSB-MP645348AAAP
CSB-EP645348AAAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anaeromyxobacter dehalogenans SsrA-binding protein (smpB) CSB-YP645349AAAP
CSB-EP645349AAAP
CSB-BP645349AAAP
CSB-MP645349AAAP
CSB-EP645349AAAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anaeromyxobacter dehalogenans Phospho-N-acetylmuramoyl-pentapeptide-transferase (mraY), partial CSB-YP645350AAAP
CSB-EP645350AAAP
CSB-BP645350AAAP
CSB-MP645350AAAP
CSB-EP645350AAAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anaeromyxobacter dehalogenans tRNA (guanine-N (7)-)-methyltransferase (trmB) CSB-YP645351AAAP
CSB-EP645351AAAP
CSB-BP645351AAAP
CSB-MP645351AAAP
CSB-EP645351AAAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anaeromyxobacter dehalogenans Methionyl-tRNA formyltransferase (fmt) CSB-YP645352AAAP
CSB-EP645352AAAP
CSB-BP645352AAAP
CSB-MP645352AAAP
CSB-EP645352AAAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anaeromyxobacter dehalogenans Dihydrodipicolinate synthase (dapA) CSB-YP645353AAAP
CSB-EP645353AAAP
CSB-BP645353AAAP
CSB-MP645353AAAP
CSB-EP645353AAAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>